US AAV Contract Development and Manufacturing Organizations Market Size study, by Workflow (Upstream Processing, Downstream Processing), by Culture Type, by Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical & Pharmaceutical Discovery, Biomedical Research), by End-User Forecasts 2022-2032
US AAV Contract Development and Manufacturing Organizations Market is valued at approximately USD 201.14 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.85% over the forecast period 2024-2032. The US Market for AAV Contract Development and Manufacturing Organizations (CDMOs) specialises in creating Adeno-Associated Virus (AAV) vectors and offering necessary services for gene therapy and biopharmaceutical development. The increasing demand for efficient AAV vector manufacturing is driven by the growing interest in gene therapies targeted at uncommon illnesses and genetic conditions. Advancements in biotechnology and gene editing techniques have expanded the scope of gene therapy, leading to a greater demand for CDMOs that specialize in AAV expertise. Collaborations between pharmaceutical companies and CDMOs are impacting market trends through enhancements in manufacturing procedures and guaranteeing compliance with regulations. The US AAV Contract Development and Manufacturing Organizations Market is poised for substantial expansion due to the healthcare industry embracing gene therapies, which will drive innovation and form strategic partnerships in this specific field.
The growth of the US AAV Contract Development and Manufacturing Organizations Market is fueled by the rising request for personalised gene therapies adjusted to the genetic profiles and medical requirements of each patient. This indicates a change towards precise medical care and specific therapies, leading to a demand for specialized AAV vectors and services offered by AAV CDMOs. However, constraints in the market are present due to regulatory obstacles, especially about safety and efficacy requirements for gene therapy items. These rules necessitate thorough testing and adherence steps that add to the intricacy and time needed for the development and production processes. Even with these difficulties, the US AAV Contract Development and Manufacturing Organizations Market is still experiencing growth and innovation due to continual improvements in gene editing technologies and biopharmaceutical research.
Major market player included in this report are:
Thermo Fischer Scientific, Inc.
Creative Biogene Inc
Catalent Inc.
Charles River Laboratories International, Inc.
Danaher Corporation
Forge Biologics
Genezen Laboratories, Inc.
Virocell Biologics, Ltd.
Pfizer Inc.
Sarepta Therapeutics, Inc.
The detailed segments and sub-segment of the market are explained below:
By Workflow
Upstream Processing
Downstream Processing
By Culture Type
Adherent Culture
Suspension Culture
By Application
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical & Pharmaceutical Discovery
Biomedical Research
By End-User
Pharmaceutical & Biopharmaceutical Companies
Academic & Research Institutes
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
The growth of the US AAV Contract Development and Manufacturing Organizations Market is fueled by the rising request for personalised gene therapies adjusted to the genetic profiles and medical requirements of each patient. This indicates a change towards precise medical care and specific therapies, leading to a demand for specialized AAV vectors and services offered by AAV CDMOs. However, constraints in the market are present due to regulatory obstacles, especially about safety and efficacy requirements for gene therapy items. These rules necessitate thorough testing and adherence steps that add to the intricacy and time needed for the development and production processes. Even with these difficulties, the US AAV Contract Development and Manufacturing Organizations Market is still experiencing growth and innovation due to continual improvements in gene editing technologies and biopharmaceutical research.
Major market player included in this report are:
Thermo Fischer Scientific, Inc.
Creative Biogene Inc
Catalent Inc.
Charles River Laboratories International, Inc.
Danaher Corporation
Forge Biologics
Genezen Laboratories, Inc.
Virocell Biologics, Ltd.
Pfizer Inc.
Sarepta Therapeutics, Inc.
The detailed segments and sub-segment of the market are explained below:
By Workflow
Upstream Processing
Downstream Processing
By Culture Type
Adherent Culture
Suspension Culture
By Application
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical & Pharmaceutical Discovery
Biomedical Research
By End-User
Pharmaceutical & Biopharmaceutical Companies
Academic & Research Institutes
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
CHAPTER 1. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET DEFINITION AND RESEARCH ASSUMPTIONS
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US AAV Contract Development and Manufacturing Organizations Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Workflow
2.2.2. By Culture Type
2.2.3. By Application
2.2.4. By End User
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET SIZE & FORECASTS BY WORKFLOW 2022-2032
5.1. Upstream Processing
5.2. Downstream Processing
CHAPTER 6. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET SIZE & FORECASTS BY CULTURE TYPE 2022-2032
6.1. Adherent Culture
6.2. Suspension Culture
CHAPTER 7. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET SIZE & FORECASTS BY APPLICATION 2022-2032
7.1. Cell & Gene Therapy Development
7.2. Vaccine Development
7.3. Biopharmaceutical & Pharmaceutical Discovery
7.4. Biomedical Research
CHAPTER 8. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET SIZE & FORECASTS BY END USER 2022-2032
8.1. Pharmaceutical & Biopharmaceutical Companies
Academic & Research Institutes
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Thermo Fischer Scientific, Inc.
9.1.2. Creative Biogene Inc
9.1.3. Catalent Inc.
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Thermo Fischer Scientific, Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Creative Biogene Inc
9.3.3. Catalent Inc.
9.3.4. Charles River Laboratories International, Inc.
9.3.5. Danaher Corporation
9.3.6. Forge Biologics
9.3.7. Genezen Laboratories, Inc.
9.3.8. Virocell Biologics, Ltd.
9.3.9. Pfizer Inc.
9.3.10. Sarepta Therapeutics, Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US AAV Contract Development and Manufacturing Organizations Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Workflow
2.2.2. By Culture Type
2.2.3. By Application
2.2.4. By End User
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET SIZE & FORECASTS BY WORKFLOW 2022-2032
5.1. Upstream Processing
5.2. Downstream Processing
CHAPTER 6. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET SIZE & FORECASTS BY CULTURE TYPE 2022-2032
6.1. Adherent Culture
6.2. Suspension Culture
CHAPTER 7. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET SIZE & FORECASTS BY APPLICATION 2022-2032
7.1. Cell & Gene Therapy Development
7.2. Vaccine Development
7.3. Biopharmaceutical & Pharmaceutical Discovery
7.4. Biomedical Research
CHAPTER 8. US AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET SIZE & FORECASTS BY END USER 2022-2032
8.1. Pharmaceutical & Biopharmaceutical Companies
Academic & Research Institutes
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Thermo Fischer Scientific, Inc.
9.1.2. Creative Biogene Inc
9.1.3. Catalent Inc.
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Thermo Fischer Scientific, Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Creative Biogene Inc
9.3.3. Catalent Inc.
9.3.4. Charles River Laboratories International, Inc.
9.3.5. Danaher Corporation
9.3.6. Forge Biologics
9.3.7. Genezen Laboratories, Inc.
9.3.8. Virocell Biologics, Ltd.
9.3.9. Pfizer Inc.
9.3.10. Sarepta Therapeutics, Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
LIST OF TABLES
TABLE 1. US AAV Contract Development and Manufacturing Organizations market, report scope
TABLE 2. US AAV Contract Development and Manufacturing Organizations market estimates & forecasts by Workflow 2022-2032 (USD Million)
TABLE 3. US AAV Contract Development and Manufacturing Organizations market estimates & forecasts by Culture Type 2022-2032 (USD Million)
TABLE 4. US AAV Contract Development and Manufacturing Organizations market estimates & forecasts by Application 2022-2032 (USD Million)
TABLE 5. US AAV Contract Development and Manufacturing Organizations market estimates & forecasts by End User 2022-2032 (USD Million)
TABLE 6. US AAV Contract Development and Manufacturing Organizations market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. US AAV Contract Development and Manufacturing Organizations market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. US AAV Contract Development and Manufacturing Organizations market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. US AAV Contract Development and Manufacturing Organizations market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. US AAV Contract Development and Manufacturing Organizations market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. U.S. AAV Contract Development and Manufacturing Organizations market estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. U.S. AAV Contract Development and Manufacturing Organizations market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 13. U.S. AAV Contract Development and Manufacturing Organizations market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 14. List of secondary sources, used in the study of US AAV Contract Development and Manufacturing Organizations Market.
TABLE 15. List of primary sources, used in the study of US AAV Contract Development and Manufacturing Organizations Market.
TABLE 16. Years considered for the study.
TABLE 17. Exchange rates considered.
TABLE 1. US AAV Contract Development and Manufacturing Organizations market, report scope
TABLE 2. US AAV Contract Development and Manufacturing Organizations market estimates & forecasts by Workflow 2022-2032 (USD Million)
TABLE 3. US AAV Contract Development and Manufacturing Organizations market estimates & forecasts by Culture Type 2022-2032 (USD Million)
TABLE 4. US AAV Contract Development and Manufacturing Organizations market estimates & forecasts by Application 2022-2032 (USD Million)
TABLE 5. US AAV Contract Development and Manufacturing Organizations market estimates & forecasts by End User 2022-2032 (USD Million)
TABLE 6. US AAV Contract Development and Manufacturing Organizations market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. US AAV Contract Development and Manufacturing Organizations market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. US AAV Contract Development and Manufacturing Organizations market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. US AAV Contract Development and Manufacturing Organizations market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. US AAV Contract Development and Manufacturing Organizations market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. U.S. AAV Contract Development and Manufacturing Organizations market estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. U.S. AAV Contract Development and Manufacturing Organizations market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 13. U.S. AAV Contract Development and Manufacturing Organizations market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 14. List of secondary sources, used in the study of US AAV Contract Development and Manufacturing Organizations Market.
TABLE 15. List of primary sources, used in the study of US AAV Contract Development and Manufacturing Organizations Market.
TABLE 16. Years considered for the study.
TABLE 17. Exchange rates considered.
LIST OF FIGURES
FIG 1. US AAV Contract Development and Manufacturing Organizations market, research methodology
FIG 2. US AAV Contract Development and Manufacturing Organizations market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US AAV Contract Development and Manufacturing Organizations market, key trends 2023
FIG 5. US AAV Contract Development and Manufacturing Organizations market, growth prospects 2022-2032
FIG 6. US AAV Contract Development and Manufacturing Organizations market, porters 5 force model
FIG 7. US AAV Contract Development and Manufacturing Organizations market, pestel analysis
FIG 8. US AAV Contract Development and Manufacturing Organizations market, value chain analysis
FIG 9. US AAV Contract Development and Manufacturing Organizations market by segment, 2022 & 2032 (USD Million)
FIG 10. US AAV Contract Development and Manufacturing Organizations market by segment, 2022 & 2032 (USD Million)
FIG 11. US AAV Contract Development and Manufacturing Organizations market by segment, 2022 & 2032 (USD Million)
FIG 12. US AAV Contract Development and Manufacturing Organizations market by segment, 2022 & 2032 (USD Million)
FIG 13. US AAV Contract Development and Manufacturing Organizations market by segment, 2022 & 2032 (USD Million)
FIG 14. US AAV Contract Development and Manufacturing Organizations market, company market share analysis (2023)
FIG 1. US AAV Contract Development and Manufacturing Organizations market, research methodology
FIG 2. US AAV Contract Development and Manufacturing Organizations market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US AAV Contract Development and Manufacturing Organizations market, key trends 2023
FIG 5. US AAV Contract Development and Manufacturing Organizations market, growth prospects 2022-2032
FIG 6. US AAV Contract Development and Manufacturing Organizations market, porters 5 force model
FIG 7. US AAV Contract Development and Manufacturing Organizations market, pestel analysis
FIG 8. US AAV Contract Development and Manufacturing Organizations market, value chain analysis
FIG 9. US AAV Contract Development and Manufacturing Organizations market by segment, 2022 & 2032 (USD Million)
FIG 10. US AAV Contract Development and Manufacturing Organizations market by segment, 2022 & 2032 (USD Million)
FIG 11. US AAV Contract Development and Manufacturing Organizations market by segment, 2022 & 2032 (USD Million)
FIG 12. US AAV Contract Development and Manufacturing Organizations market by segment, 2022 & 2032 (USD Million)
FIG 13. US AAV Contract Development and Manufacturing Organizations market by segment, 2022 & 2032 (USD Million)
FIG 14. US AAV Contract Development and Manufacturing Organizations market, company market share analysis (2023)
